[artículo] 
inJournal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 6 (Diciembre) . - pp. 29-536

Título :	Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics
Tipo de documento:	texto impreso
Autores:	Chao Cheng Lin, Autor ; Ya-Mei Bai, Autor ; Ying Chieh Wang, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 29-536
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Peso corporal, Metabólico, Obesidad, Antipsicótico, Amisulprida
Resumen:	Switching to a different second-generation antipsychotic (SGA) with a lower risk of weight gain is recommended for overweight or obese psychiatric patients undergoing SGA treatment. However, there have been no complete reports regarding the long-term metabolic effects of switching to amisulpride.
Link:	./index.php?lvl=notice_display&id=29475

[artículo] Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics [texto impreso] / Chao Cheng Lin, Autor ; Ya-Mei Bai, Autor ; Ying Chieh Wang, Autor . - 2022 . - pp. 29-536.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 6 (Diciembre) . - pp. 29-536

Palabras clave:	Peso corporal, Metabólico, Obesidad, Antipsicótico, Amisulprida
Resumen:	Switching to a different second-generation antipsychotic (SGA) with a lower risk of weight gain is recommended for overweight or obese psychiatric patients undergoing SGA treatment. However, there have been no complete reports regarding the long-term metabolic effects of switching to amisulpride.
Link:	./index.php?lvl=notice_display&id=29475